Assessment of Effects of Museum Prescription of A Montreal Museum of Fine Arts Visit Tour in Primary Care Patients

August 11, 2022 updated by: Olivier Beauchet, Jewish General Hospital

Assessment of Effects of Museum Prescription of A Montreal Museum Of Fine Arts Visit Tour in Primary Care Patients: a Cross-Sectional Study

The objective of this study is to examine effects on mental and physical health and quality of life in primary care patients visiting the Montreal Museum of Fine Arts (MMFA), this visit being prescribed by their physician. To visit the MMFA and to complete after this visit a series of self-administered questionnaires within the two days after their visit at the museum

Study Overview

Detailed Description

During the past decade, museums have become involved in the care of patients by using art to improve their quality of life and well-being. Museums have, thus, emerged as new partners in public health. Very few programs developed by museums have focused on primary care patients who are a target audience for museum health program preventions. For the development of appropriate museum programs based on visit tour, there is a need to improve knowledge the effects of a museum visit prescribed by a primary care physician in patients. The objective of this study is to examine effects on mental and physical health and quality of life in primary care patients visiting the Montreal Museum of Fine Arts (MMFA), this visit being prescribed by their physician. Based on a cross-sectional study it will be prescribed to all patients consulting their primary care physician to visit the MMFA and to complete after this visit a series of self-administered questionnaires within the two days after their visit at the museum. The period of recruitment will be one year. The outcomes are the scores of the different questionnaires.

Study Type

Observational

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Quebec
      • Montréal, Quebec, Canada, H3T 1E2
        • Jewish General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Montreal Museum of Fine Arts visitors

Description

Inclusion Criteria:

  1. ≥ 18 years old
  2. Home Internet access with an electronic device (computer, pad or cellular phone)
  3. Patient without dementia
  4. Speak the language of the recruitment centre (French or English)

Exclusion Criteria:

  1. dementia
  2. participation refusal

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Socio-demographic characteristics from the primary care physician questionnaire
Time Frame: 1 day
Primary care physician questionnaire is composed of 12 items exploring socio demographic items (age, gender), the reason perceived by the participants of the prescription and the effects of the visit on a scale form 0 (not at all) to 10 (extremely)
1 day
Mental health condition from the primary care physician questionnaire
Time Frame: 1 day
Primary care physician questionnaire is composed of 12 items exploring socio demographic items (age, gender), the reason perceived by the participants of the prescription and the effects of the visit on a scale form 0 (not at all) to 10 (extremely)
1 day
Physical health condition
Time Frame: 1 day
The Centre of excellence self-administered (CESAM) questionnaire items
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2022

Primary Completion (Anticipated)

March 13, 2024

Study Completion (Anticipated)

March 13, 2025

Study Registration Dates

First Submitted

March 13, 2020

First Submitted That Met QC Criteria

March 13, 2020

First Posted (Actual)

March 17, 2020

Study Record Updates

Last Update Posted (Actual)

August 15, 2022

Last Update Submitted That Met QC Criteria

August 11, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2020-2091

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Clinical Trials on The Centre of excellence self-administered (CESAM) questionnaire items

3
Subscribe